Physician profile
Ann D Layton
NPI 1700879970
$1,051.55
in general payments reported to CMS, 2019-2025
9 companies · $110 in 2025
The $110 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $24.27 · 2021: $343 · 2022: $224 · 2023: $206 · 2024: $144 · 2025: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $460.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $305.93 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Abbott Laboratories | $268.37 | 2021-2023 | Freestyle Libre 2, Freestyle Libre 3 |
| Dexcom, INC. | $258.04 | 2020-2024 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals Lp | $66.51 | 2024-2025 | Farxiga |
| Amarin Pharma, INC. | $44.22 | 2021 | |
| Lilly USA, LLC | $41.29 | 2021-2022 | |
| Insulet Corporation | $36.82 | 2025 | Omnipod |
| Medtronic, INC. | $18.08 | 2023 | Minimed 780g |
| Esperion Therapeutics, INC. | $12.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Layton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.